NCT05791357View on ClinicalTrials.gov

The Role of Polymerase Chain Reaction in the Management of Patients With Infective Endocarditis

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

May 31, 2024

Study Completion Date

October 31, 2024

Conditions
Endocarditis Infective
Interventions
DIAGNOSTIC_TEST

PCR (Polymerase Chain Reaction) targeting the 16 ribosomal DNA

Molecular diagnostic using a broad range PCR on obtained histological material (native valve/valve prosthesis/fragments of them)

Trial Locations (2)

00168

IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma

Policlinico Agostino Gemelli, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05791357 - The Role of Polymerase Chain Reaction in the Management of Patients With Infective Endocarditis | Biotech Hunter | Biotech Hunter